Classification Information
Pharmaceutical preparations for the treatment of catastrophic diseases, namely, focal segmental glomerulosclerosis, pantothenate kinase-associated neurodegeneration, duchenne muscular dystrophy and spinal muscular atrophy
Pharmaceuticals